Leukine (sargramostim) — Medica
Neuroblastoma
Initial criteria
- Patient is receiving Leukine in a regimen that recommends administration in combination with a granulocyte-macrophage colony stimulating factor (GM-CSF)
- Medication is prescribed by or in consultation with an oncologist
Approval duration
6 months